NVCR · NovoCure Ltd · Documents

$13.15 +0.04 (+0.31%) At close · Oct 30 Q3 2026 earnings call transcript

Market Cap

$1.54B

116.92M

Volume · Oct 30 1.97M Avg daily vol (3M) 1.44M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	AI summary	Filing Date	Period
8-K	—	2022-03-23	—
10-K	—	2022-02-24	2021-12-31
8-K	—	2022-02-24	—
8-K	—	2022-01-10	—
8-K	—	2021-12-30	—
8-K	—	2021-12-07	—
8-K	—	2021-10-28	—
10-Q	—	2021-10-28	2021-09-30
8-K	—	2021-07-29	—
10-Q	—	2021-07-29	2021-06-30
8-K	—	2021-06-11	2021-06-09
8-K	—	2021-04-29	—
10-Q	—	2021-04-29	2021-03-31
DEF 14A	—	2021-04-27	—
DEFA14A	—	2021-04-27	—
8-K	—	2021-04-13	—
10-K	—	2021-02-25	2020-12-31
8-K	—	2021-02-25	—
8-K	—	2021-02-08	2021-02-05
8-K	—	2021-02-01	2021-01-29
8-K	—	2021-01-11	—
8-K	—	2020-11-09	2020-11-06
8-K	—	2020-11-05	—
8-K	—	2020-11-03	2020-11-02
10-Q	—	2020-10-29	2020-09-30
8-K	—	2020-10-29	—
10-Q/A	—	2020-10-02	2020-06-30
10-Q/A	—	2020-10-02	2020-03-31
8-K	—	2020-08-13	2020-08-12
8-K	—	2020-08-06	2020-08-04
10-Q	—	2020-07-30	2020-06-30
8-K	—	2020-07-30	—
8-K	—	2020-07-15	—
8-K	—	2020-06-12	—
8-K	—	2020-05-13	—
10-Q	—	2020-04-30	2020-03-31
8-K	—	2020-04-30	—
DEF 14A	—	2020-04-27	2020-06-10
DEFA14A	—	2020-04-27	—
8-K	—	2020-04-24	2020-04-20
8-K	—	2020-03-06	2020-03-03
10-K	—	2020-02-27	2019-12-31
8-K	—	2020-02-27	—
8-K	—	2020-01-13	2020-01-10

Showing 101–144 of 144 filings

Key facts CIK 1645113 CUSIP G6674U108 13F (30d) 60 filings 52 filers Visit website Investor relations